Concepedia

Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B

Jens M. Kittner, Martin F. Sprinzl, Annette Grambihler, Arndt Weinmann, Jörn M. Schattenberg, Peter R. Galle, Marcus Schuchmann

Journal of Clinical Virology · 2012 · 54 citations · 13 references

DOI

Concepts

References

13

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # †

Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino et al. · Hepatology · 2008 · 483 citations · Full text

, , +17

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients #

Rami Moucari, Vincent Mackiewicz, Olivier Lada et al. · Hepatology · 2008 · 482 citations · Full text

, , +17

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

Heiner Wedemeyer, Cihan Yurdaydın, George Ν. Dalekos et al. · New England Journal of Medicine · 2011 · 474 citations · Full text

, , +13

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

E. Jenny Heathcote, Patrick Marcellin, Edward Gane et al. · Gastroenterology · 2010 · 461 citations · Full text

, , +13

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

Karsten Wursthorn, Marc Lütgehetmann, Maura Dandri et al. · Hepatology · 2006 · 439 citations · Full text

, , +17